Company Spotlight

Quotient Sciences

3080 McCann Farm Drive
Garnet Valley, PA 19060
United States
View Profile


Contract Service Directory


Worldwide Clinical Trials





Company Headquarters

600 Park Offices Drive
Suite 200
NC 27709
United States

Contract Service Directory

    Related Content

    • Breaking News | Clinical Trials
      CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin

      CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin

      Phase 2 trial will commence during the first quarter of 2021.
      Contract Pharma Staff 10.20.20

    • Breaking News | Clinical Trial Materials | Industry News | Solid Dosage/Creams/Ointments
      Hovione Starts Phase 1 Clinical Trial of HY02

      Hovione Starts Phase 1 Clinical Trial of HY02

      HY02 is a proprietary minocycline sterile ointment to treat a subset of anterior ocular inflammation
      05.26.17

    • Bio News | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
      Merck Teams With Aduro Biotech on Cancer Drug Trial

      Merck Teams With Aduro Biotech on Cancer Drug Trial

      Will evaluate the combination of Aduro’s CRS-207 with Merck’s Keytruda
      05.18.17


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Industry News
      Kemwell Provides Services for U.S. Trial

      Kemwell Provides Services for U.S. Trial

      Supplies biologics drug substance for phase 1 clinical trials for U.S. IND filing
      05.18.17

    • Clinical Trials | Drug Development | Information Technology
      Breaking New Ground: How Industry Collaboration is Transforming Clinical Research

      Breaking New Ground: How Industry Collaboration is Transforming Clinical Research

      An increasingly complex clinical trial landscape drives the life sciences industry to support broad collaborations
      Jill Johnston, Vice President, Veeva Vault, Veeva Systems 05.15.17

    • Clinical Trials
      Tracking Health

      Tracking Health

      Exploring the impact of wearable health monitoring tools on CROs
      Nigel Walker 05.09.17


    • Promotions & Moves

      Worldwide Clinical Trials Names EVP of Global BD

      Hirschman to lead business development organization
      03.30.17

    • Clinical Trials | GMPs/GCPs | Promotions & Moves | Regulatory Affairs

      Worldwide Clinical Trials Appoints Global Quality VP

      Holland to implement a risk-based clinical quality management system to ensure compliance
      01.25.17

    • Promotions & Moves

      Ancillare Appoints Asia-Pac VP

      Nitin brings 18 years of business development, management, strategic alliances, supply chain and operations experience
      12.06.16


    • Clinical Trials
      When Calls Don

      When Calls Don't Connect

      CRO revenues are being jeopardized
      07.15.16

    • Breaking News | Clinical Trials | Promotions & Moves

      CRO Analytics Appoints Bruce Wakeman as CCO

      Hiring coincides with the launch of the company’s flagship product, Performer
      08.19.15

    • Breaking News | Clinical Trials | CRO News | GMPs/GCPs | Inspections | Preclinical Outsourcing | Promotions & Moves | Regulatory Affairs | Risk Management

      Cetero Names CEO, Becomes PRACS

      Executive appointments follow sale to investors
      Gil Roth 06.21.12


    • Analytical Services | Bioanalytical Services | Breaking News | Clinical Trials | Promotions & Moves

      CEDRA Corp.

      Anthony G. Busa, Jr., has been named chief executive officer of CEDRA Corp., a division of Worldwide Clinical Trials (WCT) and a provider of Phase I clinical research and bioanalytical services.
      05.11.10